Razak Dosani
Pulmonary Disease · Fort Myers, FLNPI 1699832949
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,101 and has fallen 98.0% since, to $22 in 2022. That places this record below the midpoint for pulmonary disease clinicians in FL, where the typical reported total is $2,936.
Across 75 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$280
- AbbVie$204
- AstraZeneca$163
- Actelion Pharmaceuticals US, Inc.$151
- Mallinckrodt Enterprises LLC$69
- Boehringer Ingelheim$62
- plus $474 from 18 others
What the payments were for
- Food & beverage$1,35597%
- Education$483%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 26 | $280 |
| AbbVie | 3 | $204 |
| AstraZeneca | 10 | $163 |
| Actelion Pharmaceuticals US, Inc. | 5 | $151 |
| Mallinckrodt Enterprises LLC | 3 | $69 |
| Boehringer Ingelheim | 3 | $62 |
| Insmed, Inc. | 2 | $54 |
| Sunovion Pharmaceuticals Inc. | 3 | $45 |
| Philips North America LLC | 2 | $44 |
| Electromed, Inc. | 2 | $35 |
| Paratek Pharmaceuticals, Inc. | 2 | $32 |
| Johnson & Johnson | 2 | $29 |
| Advanced Respiratory, Inc | 1 | $29 |
| Stryker | 1 | $24 |
| Mylan Specialty L.p. | 1 | $23 |
| Shire North American Group Inc | 1 | $23 |
| Grifols USA, LLC | 1 | $23 |
| Novartis | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| La Jolla Pharmaceutical Company | 1 | $17 |
| Bayer | 1 | $16 |
| Gilead | 1 | $15 |
| Veran Medical Technologies, Inc. | 1 | $14 |
| Pfizer | 1 | $11 |
How this compares
$1,402 in reported general payments places this provider in the 35th percentile of 953 pulmonary disease providers in Florida.
Other pulmonary disease in Fort Myers
- Franck RahaghiWeston$1.2M
- Michael OttEglin Afb$909K
- Ali JiwaniOrlando$859K
- Anas HadehWeston$800K
- Jennifer FultonJacksonville$665K
- Ricardo Restrepo-JaramilloTampa$555K
- Mark RumbakTampa$528K
- Jose Soto SotoJacksonville$504K
- Javier Perez FernandezMiami$496K
- Domenick ReinaTampa$469K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.